We all respond emotionally to sound from our earliest days, when a parent’s cooing helps us form our initial bond. A New Jersey-based company is harnessing the power of sound to support individuals in recovery, with its program capturing some attention among holistically focused treatment centers.
In research published online in the Journal of Addiction Research & Therapy late last year, researchers found that patients at G&G Holistic Addiction Treatment, Inc. in Florida who received an audio therapy program from Prescription Audio, Inc. (www.prescriptionaudio.com) were able to show improvement in 10 withdrawal symptom areas.
Monty D. Moeller, Prescription Audio’s director of clinical operations, says the company’s music and audio therapy technology grew out of composer and film score producer Rod Slane’s desire to use sound to calm an anxiety-ridden world. A program that made its initial inroads directly with consumers such as parents of children with attention-deficit/hyperactivity disorder (ADHD) now has several protocols that are being marketed to organizations.
“In the addiction community, we had some specific responses that were helpful in the rehabilitation and recovery processes,” says Moeller.
The Prescription Audio product that some treatment centers have obtained is a 24-minute program combining music, natural sounds such as surf and rain, and pure tones such as those produced with tuning forks. The company sees the program as offering an adjunct to typical treatment. The “binaural beats” featured in the program are believed to have a significant influence on the brain and can contribute to reducing stress and anxiety; participants reach a restorative state during the audio sessions.
Moeller says the company recommends to its treatment center customers that clients use the audio program daily while in treatment, in a quiet and dim area that represents a safe environment. The program has guided and unguided versions, and Moeller says it takes time to “train the brain to respond” to the therapy. Still, the company believes there are few patient groups for which the technology doesn’t have promise.